Executive Leadership Series

A series of thought-provoking discussions between SCOR Global Life Executives and their fellow leaders about managing through our current environment and post-pandemic future


Leading through the COVID-19 Era 

The year 2020 will forever be remembered for COVID-19 and its massive impact around the globe. The pandemic has altered our sense of security and challenged our views on health, science, economy, politics – our world. COVID-19 and the resulting health public health crisis has changed our lives significantly – likely forever – but by how much it is still too soon to predict. Is the race to vaccinate and herd immunity our source of hope and restoration? 

Bob Wachter, Chair UCSF Department of Medicine, an academic physician, author and coronavirus expert, and Redmond Murphy, head of Business Performance, SCOR Global Life, will discuss new insights about COVID-19 and lessons learned during this 21st century pandemic.

Redmond Murphy, Head of Business Performance, SCOR Global Life, connects one-on-one
with Professor Robert M. Wachter, M.D., Chair of the Department of Medicine at the University of California, San Francisco (UCSF)


Redmond Murphy and Bob Wachter - Executive Leadership Conversation Series


Redmond Murphy

Redmond Murphy is the Head of Business Performance, SCOR Global Life and oversees global finance, actuarial and business acceptance activity for the Life business unit. Redmond, an Irish citizen, is a qualified actuary and CFA charterholder with considerable experience in the insurance and reinsurance markets and has been with SCOR since 2014. Redmond has a BSc in Mathematics and Statistics from University College Cork, Ireland and an MSc in Applied Statistics from the University of Oxford.

View Redmond Murphy's LinkedIn Profile


Robert M Wachter

Robert M. Wachter, M.D. is Professor and Chair of the Department of Medicine at the University of California, San Francisco (UCSF). He is author of 300 articles in the medical literature as well as others in the New York Times, Washington Post and Wall Street Journal. He coined the term “hospitalist” in 1996 and is often considered the “father” of the hospitalist field, the fastest growing medical specialty in U.S. history. He has written six books, including The Digital Doctor: Hope, Hype and Harm at the Dawn of Medicine’s Computer Age (2015), which was a New York Times science bestseller. His honors include selection as the most influential physician in the United States (Modern Healthcare Magazine, 2015), the Eisenberg award (nation’s top honor in patient safety, 2004) and election to the National Academy of Medicine (2020). In 2020-21, his tweets on Covid-19 were viewed over 150 million times by 170,000 followers and served as a trusted source of information on clinical, public health and policy issues surrounding the pandemic.

View Robert M. Wachter's LinkedIn Profile




Conversation Library
SCOR & Verisk
A Data-Driven World, part 1

Paolo De Martin, CEO of SCOR Global Life, connects one-to-one with...

SCOR & Verisk
A Data-Driven World, part 2

... Verisk Analytics CEO Scott G. Stephenson